Liraglutide is a once-daily injectable medication that mimics a natural GLP-1 hormone to reduce appetite, improve fullness, and regulate blood sugar.
Saxenda® is FDA-approved specifically for chronic weight management in adults with obesity or overweight and at least one weight-related condition (e.g., high blood pressure, type 2 diabetes, or high cholesterol).
Victoza® is FDA-approved for managing type 2 diabetes and may be prescribed off-label for weight loss when medically appropriate.
Liraglutide works similarly to semaglutide and tirzepatide but is dosed daily instead of weekly, making it a great option for those who prefer gradual, steady control or who do not tolerate long-acting GLP-1s.
*Final price to patient will depend on medication dosage and membership plan purchase.
✅ Adults with a BMI ≥30, or ≥27 with conditions like PCOS, insulin resistance, or prediabetes
✅ Those who don’t qualify for—or can’t afford—brand-name GLP-1s
✅ Patients seeking medically managed weight loss with ongoing support
✅ Anyone committed to sustainable, health-focused fat loss
Complete a secure online consultation
Your provider evaluates your goals, history & labs
If appropriate, you’ll receive a Saxenda / Victoza prescription
All medications come with full instructions
Track your results and get support inside our AI-powered app
Customer was compensated for their opinion. Results have not been independently verified. Individual results will vary.
💊 Saxenda / Victoza
Starting at $1349/month — includes prescription, shipping, and refill coordination.
💡 Pair it with our $199/month membership for full medical support, progress tracking, and coaching.
✅ Our Guarantee: Follow your plan or we refund your monthly membership fee. (Medication cost is non-refundable.)
Getting access to Saxenda/Victoza is simple, safe, and fast.
👉 Take the 60-second quiz
👉 Match with a provider
👉 Get personalized treatment shipped to your door
Both contain liraglutide, but:
Saxenda® is FDA-approved for weight loss.
Victoza® is FDA-approved for type 2 diabetes and may be prescribed off-label for weight loss depending on your health profile.
Liraglutide is a GLP-1 receptor agonist that slows digestion, helps you feel fuller longer, and decreases hunger hormones. It also improves insulin sensitivity and blood sugar control.
Liraglutide is administered once daily by subcutaneous injection, typically in the abdomen, thigh, or upper arm. Your provider will guide your dosing schedule.
Yes! Some patients prefer the steady, lower-dose control of daily liraglutide over weekly semaglutide or tirzepatide. It may result in fewer side effects and a gentler onset.
Most patients notice reduced appetite in the first 1–2 weeks. Weight loss typically becomes noticeable within the first month and continues gradually over time.
Yes.
Saxenda® is FDA-approved for weight management in adults (and some adolescents) with a BMI ≥30 or ≥27 with a comorbid condition.
Victoza® is FDA-approved for type 2 diabetes and may be prescribed off-label for weight loss.
Without insurance, Saxenda® can cost $1,349/month, though savings programs may reduce this. Compounded liraglutide (if available and appropriate) typically starts around $179/month.
Nausea, vomiting, constipation, diarrhea, fatigue, and mild abdominal discomfort. These are usually mild and temporary. Your provider can help adjust dosing if needed.
Saxenda® and Victoza® are FDA-approved prescription medications containing liraglutide, a GLP-1 receptor agonist indicated for weight loss and type 2 diabetes, respectively.
Saxenda® is approved for chronic weight management in adults with a BMI ≥30, or ≥27 with weight-related conditions such as high blood pressure, type 2 diabetes, or high cholesterol.
Victoza® is approved to improve blood sugar in adults with type 2 diabetes and may be used off-label for weight loss.
These medications require ongoing supervision by a licensed healthcare provider to ensure proper dose titration, management of side effects, and long-term success.
Important Warnings: Liraglutide should not be used by patients with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2). It should also not be used during pregnancy or in patients with a history of pancreatitis.
Patients should undergo a full medical consultation before starting liraglutide and review the full Medication Guide and prescribing information.
© 2025 Miami Weight Loss All rights reserved. Miami Weight Loss is a MedspaCircle.com Network
The content/images on this website are not a guarantee of individual results. Individual results may vary. The information provided on this site is for general informational purposes only, and does not replace the need for a formal consultation with a healthcare provider before undergoing a procedure or skin care treatment.
